TrimRX
US$ 25.72
glp-1 drugs weight loss effectiveness without diabetes Indications for GLP-1/GIP RA Summary Sheet and Beyond! Chart: 1 in 8 Americans
Description
View at Publisher | View at Google Scholar Green BD et al
Diala Alatassi, MD, FACP Medical Reviewer Diala Alatassi, MD, is a board-certified obesity medicine specialist who is committed to providing comprehensive, compassionate, and personalized care
Although, at first glance, it is easy to overestimate the findings and assume they apply to everyone, this studys participants were a very specific group: older adults with type 2 diabetes
Pros and Cons Circ Res
Avoid weight/obesity bias in deciding who should discontinue GLP-1RA therapy
As shown in Scheme 22
